CLINICAL_TRIALS
trial_result
· 2022-02-09
Clinical Trial Update: Treating Severe Brain-injured Patients With Apomorphine [Phase 2]
Summary
Phase 2 clinical trial investigating apomorphine for treating disorders of consciousness in severe brain-injured patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Liege | Conditions: Disorder of Consciousness | Phase 2 | Status: UNKNOWN